We last touched on Takeda Pharmaceutical Company Limited ( TAK ) back in May, at the end of the previous fiscal year. The stock was beaten down, and while we were expecting 2025 to be a challenge,I’m Jason Ditz and I have 20 years of experience in foreign policy research. My work has appeared in Forbes, Toronto Star, Minneapolis Star-Tribune, Providence Journal, Washington Times and the Detroit Free Press, as well as American Conservative Magazine and the Quincy Institute for Responsible Statecraft. I have ...